Overview

Optic Nerve Perfusion Following Treatment with Latanoprost Versus Brimionidin Tartrate

Status:
COMPLETED
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
This study aimed to evaluate the effects of topical Latanoprost 0.005 % versus Brimionidin tartrate 0.2% on perfusion of optic nerve head This prospective interventional randomized study included 56 naive patients recently diagnosed with bilateral primary open angle glaucoma equally divided into two groups with 28 patients in each group
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
Zagazig University
Treatments:
Latanoprost